Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: DAW1033D in Obstructive Sleep Apnea [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update for DAW1033D in obstructive sleep apnea (OSA) has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAW1033D

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Obstructive Sleep Apnea (OSA) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-05